CPIG
WST icon

Chicago Partners Investment Group’s West Pharmaceutical WST Stock Holding History

Chicago Partners Investment Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$975K Buy
2,742
+1,014
+59% +$310K 0.02% 666
2026
Q1 		$474K Buy
1,728
+790
+84% +$197K 0.01% 922
2025
Q4 		$222K Sell
938
-207
-18% -$56.6K 0.01% 1189
2025
Q3 		$325K Buy
+1,145
New +$278K 0.01% 904

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Chicago Partners Investment Group's WST Position: Q2 2026 in Review

Chicago Partners Investment Group increased its West Pharmaceutical (WST) stake by 59% in Q2 2026, buying an estimated $310K and bringing the position to 2,742 shares worth $975K. The position accounts for 0.02% of the portfolio, ranked #666.

Chicago Partners Investment Group first reported a position in WST in Q3 2025 and has held it in 4 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Chicago Partners Investment Group held 2,742 shares of West Pharmaceutical worth $975K as of Q2 2026.
  • Chicago Partners Investment Group bought 1,014 West Pharmaceutical shares in Q2 2026, an estimated $310K.
  • West Pharmaceutical made up 0.02% of Chicago Partners Investment Group's portfolio in Q2 2026, its #666 holding.
  • Chicago Partners Investment Group first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.